|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| Available for sale, at fair value (amortized cost of $295,747 and $226,677 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Held to maturity, at amortized cost - fair value of $494,626 (2022) and $401,524 (2021) | ||||||||||||||||||||
| Held to maturity, net of allowance for credit losses of $76 and $99 (fair value of $328,696 and $378,116 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Restricted securities, at cost | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| OREO, net | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Repossessed assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Cash surrender value on life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Interest-bearing checking | ||||||||||||||||||||
| Money market and savings | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Brokered deposits | ||||||||||||||||||||
| Total interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from FHLB - short-term | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Guaranteed preferred beneficial interest in junior subordinated debentures (“TRUPS”), net | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| Total borrowings | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, $0.01 par value per share; shares authorized 50,000,000; shares issued and outstanding 33,416,336 and 33,413,503 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
